Biofrontier Partners is a Japanese venture capital firm that focuses on life science companies. The firm seeks early stage investments in biotechnology, pharmaceuticals, genomics, proteomics, drug delivery, diagnostics, medical devices, agbio, food sciences, and new biomaterials sectors.
Venture Capital
4 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.